Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor, B; Segurado, R; Kennelly, S; Olde Rikkert, MGM; Howard, R; Pasquier, F; Börjesson-Hanson, A; ... NILVAD Study Group, ; + view all Lawlor, B; Segurado, R; Kennelly, S; Olde Rikkert, MGM; Howard, R; Pasquier, F; Börjesson-Hanson, A; Tsolaki, M; Lucca, U; Molloy, DW; Coen, R; Riepe, MW; Kálmán, J; Kenny, RA; Cregg, F; O'Dwyer, S; Walsh, C; Adams, J; Banzi, R; Breuilh, L; Daly, L; Hendrix, S; Aisen, P; Gaynor, S; Sheikhi, A; Taekema, DG; Verhey, FR; Nemni, R; Nobili, F; Franceschi, M; Frisoni, G; Zanetti, O; Konsta, A; Anastasios, O; Nenopoulou, S; Tsolaki-Tagaraki, F; Pakaski, M; Dereeper, O; de la Sayette, V; Sénéchal, O; Lavenu, I; Devendeville, A; Calais, G; Crawford, F; Mullan, M; NILVAD Study Group, ; - view fewer (2018) Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Medicine , 15 (9) , Article e1002660. 10.1371/journal.pmed.1002660 . Green open access

https://ift.tt/2y6SUkn